MOTS-c dosage questions come up a lot in longevity and metabolic research circles, but there is not much plain-language guidance out there to answer them. This guide explains what MOTS-c actually is, what the research so far has found, and how MOTS-c is measured out, mixed, and handled once it reaches a research lab.
What Is MOTS-c?
MOTS-c is a short peptide, a chain of just 16 amino acids, with an unusual origin story. Most peptides are copies of a hormone or a piece of a hormone. MOTS-c is different: it comes from the tiny set of genetic instructions carried inside mitochondria, the structures inside our cells that generate energy. Scientists had assumed the specific stretch of mitochondrial DNA that produces MOTS-c only made a structural building block for the cell, so finding an active peptide hiding there was a genuine surprise.
- Discovered in 2015. A research team led by Dr. Changhan Lee at the University of Southern California first identified MOTS-c, adding it to a small but growing family of compounds called mitochondrial-derived peptides.
- Studied mainly for its role in muscle and energy use. Research has focused on how MOTS-c affects the way skeletal muscle handles energy, which is a different area of study than the growth hormone peptides covered elsewhere on this site.
- Called an “exercise mimetic.” MOTS-c levels rise naturally in the body during physical activity, which is why researchers discuss it alongside exercise science rather than purely as a growth or repair compound.
- Not an approved drug. MOTS-c has not been evaluated or approved by the FDA for any use, and no human clinical trial giving people a set dose of MOTS-c has been published.
- Banned in competitive sports. The World Anti-Doping Agency added MOTS-c to its prohibited substances list starting in 2024, a detail that sets it apart from most other peptides discussed on this site.
How Does MOTS-c Work?
In cell studies, MOTS-c attaches to an enzyme called casein kinase 2, which sits along a signaling chain connected to how cells sense and use energy. That chain runs through a system called AMPK, best thought of as a cell’s internal fuel gauge: it switches on when a cell needs to manage its energy use more carefully. Research suggests MOTS-c has a hand in switching that fuel-gauge system on, mainly inside muscle tissue.
Because MOTS-c naturally rises in the body during exercise, and because it appears to trigger some of the same energy-management responses exercise does, researchers describe it as an exercise mimetic. That framing places MOTS-c research alongside exercise physiology, rather than treating it as a straightforward growth or repair peptide the way many other compounds on this site are studied.
What Has MOTS-c Research Found?
Almost everything documented about MOTS-c so far comes from studies in mice, not from giving the peptide to human research volunteers at a set dose.
- The original 2015 study reported broad metabolic effects in mice. Lee and colleagues found that MOTS-c helped prevent age-related and diet-related insulin resistance and prevented diet-induced obesity in mouse models, alongside improvements in physical performance and healthy lifespan.
- A 2016 follow-up review expanded on the muscle-and-fat connection. The same research group summarized MOTS-c’s role in how skeletal muscle and fat tissue manage energy, building on the original findings rather than adding new human data.
- Human interest so far comes from exercise studies, not injection studies. A 2021 study measured naturally occurring MOTS-c levels in breast cancer survivors before and after a structured exercise program, connecting the peptide to natural exercise physiology rather than to any administered research dose.
- A 2023 review looked at MOTS-c across a wider range of metabolic research. It summarized findings on MOTS-c and metabolic disorders, reflecting a growing body of preclinical interest in the compound.
- None of this confirms an effect from injecting MOTS-c into humans. The animal data and the human exercise data both point toward the same biological pathway, but neither one substitutes for a dedicated human dosing trial, which has not been done yet.
- MOTS-c’s mitochondrial origin also places it in a different research lane than the receptor-binding peptides covered elsewhere on this site, such as ipamorelin or CJC-1295, which work by attaching to a hormone receptor from outside the cell. MOTS-c instead appears to influence energy metabolism from inside the cell, through a pathway tied to the mitochondria’s own genetic material. NAD+ is sometimes mentioned in the same conversation for a similar reason: it also supports cellular energy production, though through a completely different route, as a coenzyme rather than a peptide.
MOTS-c Dosage, Injections, and Handling
MOTS-c does not have an established or approved human dosage, since it has never been approved for any use and no human dosing trial has been published. The mouse studies behind MOTS-c’s research reputation used injected doses designed for mouse-sized bodies, and converting an animal dose into a human-equivalent figure involves assumptions this guide will not attempt, especially with no human trial available to check the result against. Anything sold as MOTS-c research material is intended for laboratory research by qualified professionals, not a personal dosing plan.
What this guide can walk through is the reconstitution math, meaning how MOTS-c research material is mixed and measured once it arrives as a freeze-dried powder in a vial.
- Work out the concentration. Concentration (mg/mL) equals the vial’s labeled strength in milligrams divided by however much liquid is added. A 5mg vial mixed with 2mL of bacteriostatic water, for example, produces a 2.5 mg/mL solution.
- Add the liquid carefully. Bacteriostatic water, sterile water with a small amount of preservative added, should be added slowly down the inside wall of the vial rather than poured directly onto the powder, then mixed with a gentle swirl rather than a shake, since shaking can damage the peptide.
- Let our calculator do the math. Our peptide reconstitution calculator takes the vial strength and the amount of water added and returns the concentration directly, which is more reliable than working it out by hand, especially with no standard human dose to double-check the result against.
- Store it cold and dark. Unreconstituted MOTS-c should stay refrigerated or frozen and out of direct light. Once mixed, the solution should be kept refrigerated and used within the window stated in the supplier’s documentation, since a reconstituted solution is far more sensitive to time and temperature than the freeze-dried powder.
- Avoid the most common mixing mistakes. These include guessing at the concentration instead of calculating it, shaking instead of swirling, leaving a mixed vial out at room temperature, and forgetting that a syringe retains a small amount of liquid in its needle and hub, which can throw off a carefully measured volume if it is not accounted for.
ANTI-AGING
MOTS-C
Side Effects and Safety
Because no published human trial has given people a set dose of MOTS-c, there is no clinical safety record to point to the way there is for some other, more established peptides.
- The animal research was not designed as a safety study. The mouse studies behind MOTS-c’s findings measured metabolic and performance outcomes, not a structured safety profile, so they do not offer the kind of side-effect data a dedicated safety trial would.
- The WADA ban is not a safety statement. Being placed on a prohibited substances list reflects a concern about performance-enhancing potential and fairness in competition, not a documented health risk, though it does confirm regulators consider MOTS-c biologically active enough to matter.
- Long-term human safety data does not exist yet. Unlike some peptides that at least have one small human trial behind them, MOTS-c has none, which makes any general safety claim, positive or negative, unsupported.
- No reported problems is not the same as proven safety. With this little human research available, the absence of documented side effects reflects a lack of research rather than a demonstrated clean safety record.
This content is provided for Research Use Only (RUO). The compounds discussed are not drugs, dietary supplements, foods, or cosmetics, and are not intended for human or animal consumption, diagnostic use, or therapeutic use of any kind. They have not been evaluated by the FDA for safety or efficacy in humans. Any research use must be conducted by qualified professionals in a controlled laboratory environment, in accordance with all applicable institutional, local, and federal regulations.
FAQ
What is MOTS-c?
MOTS-c is a short, 16-amino-acid peptide encoded by mitochondrial DNA rather than the cell’s main genetic material, discovered in 2015 by a research team at the University of Southern California and studied mainly for its role in energy metabolism.
What does research show about MOTS-c so far?
Mouse studies have linked MOTS-c to reduced insulin resistance, reduced diet-induced obesity, improved physical performance, and longer healthy lifespan. A separate human study found that exercise changes naturally occurring MOTS-c levels, but no trial has tested an administered dose of the peptide in people.
Is there an official MOTS-c dosing schedule for research use?
No. Since MOTS-c has never been approved for any use and no human trial has published a dosing protocol, there is no official number to reference.
What are the known side effects of MOTS-c?
There is no dedicated human safety trial to report on, since MOTS-c has never been given to human volunteers at a set research dose. The animal studies were designed to study metabolism, not safety, so they do not offer a side-effect profile either.
Is MOTS-c banned in sports?
Yes. The World Anti-Doping Agency added MOTS-c to its list of prohibited substances starting in 2024.
Is MOTS-c approved for human use?
No. MOTS-c is sold strictly for laboratory research use and has not been evaluated by the FDA for safety or efficacy in humans.
Sources
- Wikipedia. MOTS-c, its discovery, mitochondrial origin, and regulatory status.
- Lee C, Zeng J, Drew BG, Sallam T, Martin-Montalvo A, Wan J, Kim SJ, Mehta H, Hevener AL, de Cabo R, Cohen P. (2015). The Mitochondrial-Derived Peptide MOTS-c Promotes Metabolic Homeostasis and Reduces Obesity and Insulin Resistance. Cell Metabolism.
- Lee C, Kim KH, Cohen P. (2016). MOTS-c: A Novel Mitochondrial-Derived Peptide Regulating Muscle and Fat Metabolism. Free Radical Biology and Medicine.
- Dieli-Conwright CM, et al. (2021). Effect of Aerobic and Resistance Exercise on the Mitochondrial Peptide MOTS-c in Breast Cancer Survivors. Scientific Reports.
- Gao Y, et al. (2023). MOTS-c Functionally Prevents Metabolic Disorders. Metabolites.
MOTS-c sits in the same research category as other anti-aging compounds discussed on this site, including the GHK-Cu benefits research covered separately.
